Listed since August 2026
Shifa Laboratories (Pvt) Ltd is a Lahore-based pharmaceutical company associated with the manufacturing and supply of pharmaceutical products in Pakistan. The company has been documented in Pakistani pharmaceutical industry records for several years and is listed in regulatory and industry sources as Shifa Laboratories (Pvt) Ltd. Its recorded Lahore location is in the Industrial Estate/Gulberg area.
Public business and industry directories list Shifa Laboratories at 39, Industrial Estate, Gulberg-III, Lahore, while current business mapping data places the company around 40 Gurumangat Road, Industrial Area, Lahore. These records appear to refer to the same industrial-area operation, although the address formatting differs between sources.
Shifa Laboratories is categorized as a pharmaceutical company rather than a patient-facing clinical diagnostic laboratory. Historical industry records identify the company in connection with Pakistan's pharmaceutical manufacturing sector, while more recent regulatory documentation from the Drug Regulatory Authority of Pakistan lists M/s Shifa Laboratories (Pvt) Ltd. among licensed pharmaceutical companies.
The company's primary profile is related to pharmaceutical manufacturing and the production and supply of medicines. Pharmaceutical manufacturing involves controlled processes for the preparation, processing, packaging and quality management of medicinal products according to applicable regulatory requirements.
Shifa Laboratories appears in official DRAP documentation. In the minutes of the 291st meeting of the Central Licensing Board held in May 2023, M/s Shifa Laboratories (Pvt) Ltd. is listed with a manufacturing licence reference. This provides regulatory evidence of the company's presence within Pakistan's pharmaceutical manufacturing sector.
The company has a documented history within Pakistan's pharmaceutical industry. A University of the Punjab publication on the Pakistani pharmaceutical industry lists Shifa Laboratories (Pvt) Ltd. at 39-Industrial Estate, Gulberg-III, Lahore and identifies M. Muhammad Younas Malik as Managing Director.
An older UNIDO industry report also records Shifa Laboratories and identifies its management and Lahore manufacturing location, demonstrating that the company has been part of the country's pharmaceutical sector for many years.
Pharmaceutical companies must operate within applicable regulatory frameworks governing medicinal products, manufacturing facilities and quality systems. The presence of Shifa Laboratories in DRAP licensing documentation indicates that the company has been subject to Pakistan's pharmaceutical regulatory framework. Individual products and manufacturing activities may have separate regulatory requirements.
The Industrial Estate/Gulberg area of Lahore is an established commercial and industrial zone. Shifa Laboratories' recorded location within this area is consistent with its role as a pharmaceutical manufacturing organization rather than a conventional walk-in diagnostic laboratory.
Publicly available business directories list the company telephone numbers as 042-35717981 and 042-35717984, with fax number 042-35764527. Older industry records also contain related contact information. Because directory information can change over time, current contact details should be verified before publication as official contact information.
Older industry and business directories associate Shifa Laboratories with shifalaboratories.com. However, a currently functioning official company website and updated product catalogue could not be independently verified during this research. Therefore, specific product information should not be inferred from the website address alone.
Shifa Laboratories is associated with pharmaceutical products and manufacturing rather than clinical pathology testing. A pharmaceutical manufacturer may work with different medicinal formulations and dosage forms depending on its licensed manufacturing scope. The exact current product catalogue should be confirmed from current company or DRAP records.
It is important not to confuse Shifa Laboratories (Pvt) Ltd. Lahore with Shifa Clinical Laboratories in Hayatabad, Peshawar. The latter is a patient-facing diagnostic laboratory offering clinical tests, while Shifa Laboratories (Pvt) Ltd. is documented as a pharmaceutical company.
For a medical or healthcare directory, Shifa Laboratories (Pvt) Ltd. is best classified under Pharmaceutical Companies, Pharmaceutical Manufacturing, or Medicine Manufacturers rather than Medical Diagnostic Laboratories.
Public records confirm the company's pharmaceutical-industry identity, Lahore location and regulatory presence. However, a complete current list of manufactured products, dosage forms, therapeutic categories, manufacturing capacity, prices and distribution arrangements was not found in sufficiently reliable current sources. These details should be verified directly with the company or through current DRAP records.
Shifa Laboratories (Pvt) Ltd. is a Lahore-based pharmaceutical manufacturer with a documented history in Pakistan's pharmaceutical industry. Its public records place it in the Industrial Estate/Gulberg area of Lahore and identify it as a pharmaceutical company. DRAP records also list the company among pharmaceutical manufacturers subject to the country's regulatory framework.
The primary documented activity of Shifa Laboratories (Pvt) Ltd. is pharmaceutical manufacturing. The company is listed as a pharmaceutical company in Pakistani business directories and appears in DRAP licensing documentation. Its activities therefore relate to the production and supply of medicinal products rather than routine patient laboratory testing.
Shifa Laboratories is associated with the production and supply of pharmaceutical medicines. Pharmaceutical production involves controlled manufacturing processes designed to maintain product quality, consistency and compliance with applicable regulatory requirements.
Pharmaceutical manufacturing may include formulation, processing, filling, packaging and quality-control activities depending on the products and manufacturing categories authorized for a particular facility. The exact formulation categories currently operated by Shifa Laboratories were not sufficiently documented in the public sources reviewed and therefore should not be listed as confirmed individual services.
Quality control is an essential part of pharmaceutical manufacturing. It can involve examination of raw materials, production-stage controls and finished-product testing to ensure that products meet applicable specifications. The exact internal laboratory procedures and equipment used by Shifa Laboratories are not publicly documented in enough detail to provide a verified technical list.
The company can be categorized as a finished pharmaceutical manufacturer based on its presence in Pakistan's pharmaceutical industry and DRAP licensing records. Specific medicines, strengths, formulations and pack sizes should be confirmed from current regulatory or company documentation.
Packaging is an important component of medicinal-product manufacturing because it protects products and provides essential information such as product identification, batch information, manufacturing details and expiry information. The exact packaging operations of Shifa Laboratories are not independently documented in the current sources reviewed.
Shifa Laboratories has appeared in DRAP regulatory documentation. Its inclusion in Central Licensing Board records demonstrates that the company operates within Pakistan's pharmaceutical regulatory framework. Individual products may have their own registration, enlistment or approval requirements.
Pharmaceutical manufacturers support the healthcare supply chain by producing medicines for distribution through appropriate commercial and healthcare channels. Shifa Laboratories has been listed in industry directories as a pharmaceutical company in Lahore, indicating its participation in this sector.
The company has a long-standing presence in Pakistani pharmaceutical industry records. Historical sources identify its management and Lahore industrial location, while business directories provide contact information for the company.
Pharmaceutical companies may undertake formulation development and product-related technical activities as part of their manufacturing operations. However, a dedicated current product-development portfolio for Shifa Laboratories was not found in the sources reviewed, so specific research or development capabilities should not be stated as confirmed.
Manufacturing support can include raw-material handling, production processes, quality checks, packaging and documentation. The exact scope of these activities at Shifa Laboratories depends on its currently licensed manufacturing operations.
Maintaining appropriate regulatory documentation is an important requirement for pharmaceutical manufacturers. Shifa Laboratories' presence in DRAP licensing records provides evidence that its pharmaceutical operations fall under the relevant Pakistani regulatory framework.
Pharmaceutical manufacturing is connected to medicine distribution and healthcare supply networks. Publicly available records identify Shifa Laboratories as a pharmaceutical company but do not provide a current, complete list of distributors, retail partners or geographic distribution territories.
A complete and current product catalogue was not located in reliable public sources during this research. For this reason, individual medicine names, prices, therapeutic claims, strengths or pack sizes should not be added to a directory record without verification.
Shifa Laboratories (Pvt) Ltd. should not be described as a clinical pathology laboratory offering CBC, liver function tests, kidney function tests, urine analysis or other patient diagnostic investigations. The available evidence identifies it as a pharmaceutical manufacturing company.
For directory purposes, the safest verified service description is pharmaceutical manufacturing, medicine production, pharmaceutical processing, quality-control activities and pharmaceutical product supply, with the exact product and manufacturing scope subject to current regulatory confirmation.
Shifa Laboratories (Pvt) Ltd. represents a pharmaceutical manufacturing entity in Lahore with a long-established presence in Pakistan's pharmaceutical industry. Its documented regulatory and industry records support classification as a pharmaceutical company rather than a diagnostic laboratory.